Entoura is an Australian owned and operated healthcare company, developing and supplying high quality medicinal cannabis products, training and education.
Entoura was established in 2018 by Professor Ian Brighthope, who was a co-founder of acnem and President of the College for 27 years. Professor Brighthope also founded Nutrition Care Pharmaceuticals, one of Australia’s exclusive companies in its ability to both formulate and manufacture therapeutic nutraceutical medicines.
Entoura’s vision is to open new pathways for previously inaccessible practitioner – patient treatment intervention.
Entoura is committed to developing high-quality innovative therapeutics, supported by outstanding research programs, validated with clinical evidence and disseminated via exceptional education programs.
Medicinal Cannabis has a long history. It was first used as long ago as 400 AD and introduced into Western Medicine around 1840. In fact, it was used quite extensively up until prohibition in 1937.
Medicinal cannabis is derived from the cannabis plant – also known as hemp or marijuana.
Cannabis is a complex plant, containing over 400 compounds.
Entoura has achieved a significant milestone with the release of clinical trial results demonstrating its medicinal cannabis product Entoura 10:15 Oil is an effective treatment for people suffering from insomnia.
The National Institute of Integrative Medicine (NIIM) has released the preliminary findings of this randomised, double-blind, placebo controlled, cross-over study and is in the process of submitting for journal publication.
This study is the first of its kind to include midnight melatonin levels to assess the effect of medicinal cannabis oil on sleep quality in adults with insomnia.
Key outcomes of the trial included:
Entoura has launched a range of food grade terpenes in organic hemp seed oil. Produced under GMP in Switzerland, each product has a blend of 14-16 terpenes with the added benefits of rosemary, blended in organic Hemp Seed Oil.